Recently Featured

Takeda Plans 4,500 Layoffs as Part of Major Restructuring Effort

May 24, 2026
Takeda’s multiyear restructuring initiative is set to eliminate approximately 4,500 positions by the end of the 2026 fiscal year, incurring restructuring costs estimated at 170 billion Japanese yen (approximately $1.07 billion). This strategic move is anticipated to yield gross savings of around 100 billion yen ($633 million) for the same period. This significant workforce reduction…

Podcast Highlights Importance of Community Oncology in U.S. Healthcare

May 24, 2026
This podcast episode explores the critical role community oncology plays in the U.S. healthcare system and why supporting its growth and autonomy matters for patients and providers. The discussion emphasizes how community oncology not only enhances patient access to care but also fosters a more personalized treatment approach, which is essential in the fight against…

Merck KGaA Sees Increased Demand Amid Iran Conflict, Boosting Guidance

May 24, 2026
Merck KGaA is experiencing a notable increase in demand for its laboratory equipment, driven by clients stockpiling supplies in response to the ongoing conflict in Iran. This surge in demand has prompted the company to raise its financial guidance, reflecting a strategic adaptation to market dynamics influenced by geopolitical tensions. The backdrop of the Iran…

MHRA Updates Guidelines for Medicines Pipeline Data Submission

May 24, 2026
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued new guidelines detailing how Marketing Authorisation Holders (MAHs) can submit information regarding planned or potential future submissions. This development is significant as it aims to enhance transparency and communication between the regulatory body and pharmaceutical companies, ensuring that stakeholders are well-informed about upcoming market…

Ongoing Cases